Evidence map›Paper›PMID 39712632›Full record

ArticleClinical interventions in aging2024

Characteristics of Mortality After Endovascular Thrombectomy in Patients with Acute Ischemic Stroke.

Jian Wang, Qian Liu, Fayun Hu, Hongbo Zheng, Xin Jiang, Lizhang Chen, Muke Zhou, Jian Guo, Hong Chen, Fuqiang Guo and 4 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical interventions in aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jian Wang *Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Qian Liu *Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Fayun Hu *Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Hongbo ZhengDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Xin JiangDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Lizhang ChenDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Muke ZhouDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Jian GuoDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Hong ChenDepartment of Neurology, Deyang People's Hospital, Deyang, Sichuan, People's Republic of China.
Fuqiang GuoDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China.
Yufeng TangDepartment of Neurology, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, Sichuan, People's Republic of China.
Jinglun LiDepartment of Neurology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Dong ZhouDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Li HeDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Despite significant advancements in the treatment of acute ischemic stroke (AIS) with endovascular thrombectomy (EVT), post-EVT mortality remains a considerable concern. However, there is a lack of real-world epidemiological data delineating the characteristics of mortality for EVT, particularly in recent years following the widespread promotion of EVT treatment for stroke patients. Methods: This multicenter, retrospective study collected data from 721 AIS patients who died following EVT across 33 hospitals in Sichuan Province, China, from January 2019 to September 2022. The analysis sought to identify the primary causes of death within 30 days post-EVT and explore their related clinical features. Results: The leading causes of death were malignant cerebral edema (MCE) in 365 patients (50.6%), pneumonia in 180 patients (25%), and symptomatic intracranial hemorrhage (sICH) in 94 patients (13%). MCE was the predominant cause of death in anterior circulation strokes, while pneumonia prevailed in posterior circulation strokes. MCE was also the primary cause of death within one week post-EVT, but pneumonia became increasingly dominant over time. Large vessel occlusion and lower reperfusion success rate were significantly correlated with MCE. Advanced age increases the risk of death from pneumonia. Tandem occlusion and procedural complications tend to correlate with mortality from sICH. Conclusion: This study revealed that the principal causes of death after EVT included MCE, sICH, and pneumonia. MCE was found to be correlated with unsuccessful reperfusion. sICH was associated with procedural complications and the operators' experience. Pneumonia was linked to post-EVT management, particularly for those who survived for one week.

Indexed as

Endovascular ProceduresIschemic StrokeThrombectomyAgedAged, 80 and overBrain EdemaCause of DeathChinaFemaleHumansIntracranial HemorrhagesMaleMiddle AgedPneumoniaPostoperative ComplicationsRetrospective Studiesacute ischemic strokecerebral edemaendovascular thrombectomyintracranial hemorrhagemortalitypneumonia

Identifiers

PMID39712632
PMCPMC11662908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.